ReviewFrontiers in immunology2022

Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer.

Anna Passarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.